Tuesday , February 7 2023

Resistant bacteria cost a lot of life and money, warns the OECD


Antibiotic-resistant bacteria not only endanger life but also weigh health systems: they could up to $ 3.5 billion by 2050 in each OECD country, according to a report published on Wednesday, 7 November.

"These bacteria are more expensive than flu, AIDS and tuberculosis, and will cost even more if countries fail to address this problem," AFP's Public Health Specialist Michele Cechini said. OECD (Organization for Economic Co-operation and Development).

According to him countries in the treatment of antibiotic-resistant bacteria already spend on average 10% of their health budgets.

According to a forecast in a report covering 33 of the 36 OECD countries, resistant bacteria could kill 2.4 million people in Europe, North America and Australia by 2050.

Reported by a separate study published on Monday in the area of ​​Lancet Infectious Diseases The number of 33,000 deaths attributed to these bacteria in 2015 The European Union.

However, according to the OECD, we can fight them with "simple measures" at a moderate cost: "promote better hygiene" (by encouraging, for example, washing hands); "stopping antibiotic overwriting"; or further generalizing quick diagnostic tests to determine if the infection is a virus (in this case antibiotics are not usable) or a bacterium.

According to the OECD, these measures would only cost US $ 2 per person per year preventing three-quarters of the deaths.

"Investing in a major public health program that includes some of these measures can be written off in one year and will save $ 4.8 billion a year," says the OECD.

Health authorities, from the World Health Organization (WHO), regularly warn danger of overuse of antibiotics, resistant to a huge bacteria. Children and elderly people are particularly at risk.

"Brazil, Indonesia and Russia 40 to 60% of infections are already durable, compared to an average of 17% in OECD countries, "said the minister.

Even more alarming is the fact that "resistance to second- or third-line antibiotics will be 70% higher in 2005 than in 2005". These antibiotics are those that are intended to be used as a last resort if there is no other solution.


Source link